Cargando…
M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE
Autor principal: | Breidenbaugh, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566850/ http://dx.doi.org/10.1016/j.anai.2021.08.218 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis to excipient polyethylene glycol: case report
Publicado: (2021) -
Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy
por: McSweeney, Morgan D., et al.
Publicado: (2021) -
Non–immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol
por: Jiang, Shirley Y., et al.
Publicado: (2021) -
Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
por: Garvey, Lene H., et al.
Publicado: (2021) -
PEG That Reaction: A Case Series of Allergy to Polyethylene Glycol
por: Cox, Fionnuala, et al.
Publicado: (2021)